tirzepatide dysesthesia In four recent placebo-controlled clinical trials, dysesthesia, an unpleasant sensation that's perceived on or under the skin, was reported as a side effect of the GLP-1 agonist semaglutide in 5-23% of recipients Tirzepatide vs. Semaglutide for Weight
Description
Regular follow-ups with your provider help make sure youre on track and adjustments can be made if progress slows

These trials demonstrated that Mounjaro significantly reduced sleep apnea severity in adults with obstructive sleep apnea (OSA) and obesity

10.2337/db23-127-OR 77.Wilson JM, Nikooienejad A, Robins DA, et al

2024;167(2):402404.e3

Quick summary Compounded tirzepatide is the same active drug as Zepbound and Mounjaro, but it is mixed by a compounding pharmacy and is not FDA-approved
